|
Website:
http://www.actelion.com
Phone: +41 61 565 65 65 |
Address:
Gewerbestrasse 16
4123 Allschwil, |
Company Description
Actelion AG(ACTELION). The Group's principal activity is to discover, develop and market low molecular drugs for human health care. The Group's products include Tracleer for the treatment of pulmonary arterial hypertension and Zavesca for the treatment of Type I Gaucher's disease. The Group's operations are located in North America, Europe, Asia-Pacific, Australia and Brazil. Discovers, develops and markets low molecular drugs for high unmet medical needs
Key People
| Chairman & Chief Executive | Jean-Paul Clozel |
| Vice Chairman & Chief Financial Officer | Andrew J. Oakley |
| Chief Executive | Robert E. Cawthorn |
| Vice President | Andre J. Mueller |
Related Business Topics
